Literature DB >> 16266221

Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease.

M Barreiro1, C Núñez, J E Domínguez-Muñoz, A Lorenzo, F Barreiro, J Potel, A S Peña.   

Abstract

OBJECTIVE: The aim of this study is to assess the importance of NOD2/CARD15 gene mutations as prognostic factors for surgical indications in Crohn's disease. PATIENTS AND EXPERIMENTAL
DESIGN: A total of 165 Crohn s disease patients were studied, considering previous surgery related to Crohn's disease. We analyzed for previous surgery in global procedures as well as separately for the two main surgical indications: ileal resection and fistula treatment. The need for appendectomy was also studied. All patients were genotyped for the three CARD15 mutations, and association studies were developed using Chi-square statistics and Fisher's exact test whenever appropriate.
RESULTS: Carriers of the G908R or 1007fs mutation needed surgery more frequently, both for ileal resection and fistula repair. In contrast, appendectomy was not associated with CARD15 mutations.
CONCLUSIONS: As previously reported in this population, the R702W mutation does influence parameters of disease or need of surgery. The need for Crohn's disease-related surgery is higher in carriers of the G908R or 1007fs CARD15 mutation in the Galician population. Nevertheless, the frequency of these mutations does not allow their use to predict the course of disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266221     DOI: 10.4321/s1130-01082005000800002

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  6 in total

1.  1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery.

Authors:  Ali Tüzün Ince; Ozden Hatirnaz; Oya Ovünç; Uğur Ozbek
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer.

Authors:  Inés Omrane; Amel Mezlini; Olfa Baroudi; Nejla Stambouli; Karim Bougatef; Hager Ayari; Imen Medimegh; Hassen Bouzaienne; Nancy Uhrhammer; Yves-Jean Bignon; Amel Benammar-Elgaaied; Raja Marrakchi
Journal:  Med Oncol       Date:  2014-04-10       Impact factor: 3.064

Review 4.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

5.  Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Authors:  Maneesha Bhullar; Finlay Macrae; Gregor Brown; Margie Smith; Ken Sharpe
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

6.  Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy.

Authors:  Inés Omrane; Imen Medimegh; Olfa Baroudi; Hager Ayari; Walid Bedhiafi; Nejla Stambouli; Marwa Ferchichi; Nadia Kourda; Yves-Jean Bignon; Nancy Uhrhammer; Amel Mezlini; Karim Bougatef; Amel Benammar-Elgaaied
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.